Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -91,432 | -56,150 | -28,076 | -100,294 | -97,361 |
| Depreciation Amortization | 1,041 | 842 | 417 | 2,028 | 1,761 |
| Income taxes - deferred | N/A | N/A | N/A | -70 | N/A |
| Accounts receivable | 963 | 719 | 865 | 457 | 625 |
| Accounts payable and accrued liabilities | 2,924 | -3,326 | -1,302 | 1,266 | 6,587 |
| Other Working Capital | -3,617 | -5,778 | 462 | 2,292 | 5,801 |
| Other Operating Activity | 8,973 | 8,030 | 4,149 | 18,699 | 11,423 |
| Operating Cash Flow | $-81,148 | $-55,663 | $-23,485 | $-75,622 | $-71,164 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,446 | -70,505 | -70,978 | -110,509 | 60,535 |
| PPE Investments | -329 | -146 | -13 | 2,090 | 1,762 |
| Investing Cash Flow | $7,117 | $-70,651 | $-70,991 | $-108,419 | $62,297 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 84,135 | N/A |
| Debt Repayment | -1,379 | -912 | -456 | -1,710 | -1,268 |
| Common Stock Issued | 114 | 0 | 0 | 202,270 | 325 |
| Common Stock Repurchased | -357 | -357 | -357 | -887 | -887 |
| Other Financing Activity | 61 | 61 | -17 | 0 | -27 |
| Financing Cash Flow | $-1,561 | $-1,208 | $-830 | $283,808 | $-1,857 |
| Beginning Cash Position | 137,266 | 137,266 | 137,266 | 37,499 | 37,499 |
| End Cash Position | 61,674 | 9,744 | 41,960 | 137,266 | 26,775 |
| Net Cash Flow | $-75,592 | $-127,522 | $-95,306 | $99,767 | $-10,724 |
| Free Cash Flow | |||||
| Operating Cash Flow | -81,148 | -55,663 | -23,485 | -75,622 | -71,164 |
| Capital Expenditure | -664 | -480 | -17 | -80 | -46 |
| Free Cash Flow | -81,812 | -56,143 | -23,502 | -75,702 | -71,210 |